概括
血小板存活时间在患有 mitra 透和风湿性心脏病的患者中经常缩短,增加了血栓栓塞的风险. 这项研究研究了这些患者群体的血小板存活率.
科学领域:
- 心脏病学 心脏病学
- 血液学 血液学 血液学
- 血管医学 血管医学
背景情况:
- 血栓栓塞栓症 (TE) 是类风湿性米特拉病的重要并发症.
- 血小板存活时间与这些患者的TE发生有关.
- 密特拉预落与 TE 的发病率较低有关.
研究的目的:
- 在患有心肌脱落 (MVP) 和风湿性心脏病 (RHD) 的患者中调查血小板存活时间.
- 为了比较MVP和RHD患者之间的血小板存活时间缩短的频率,有和没有TE病史.
- 评估硫芬皮拉对MVP患者血小板存活率的影响.
主要方法:
- 血小板存活率被评估使用自主标记与-51.
- 患者组包括那些患有 mitra prolapse 和那些患有风湿性心脏病的患者.
- 在有中风病史的患者中进行了脑血管动脉造影.
主要成果:
- 缩短了血小板存活时间被观察到在患有额头骨缩的患者中,他们曾经经历过TE.
- 在没有TE的患者中,缩短血小板存活率在RHD (78%) 比MVP (33%) 更频繁.
- 硫芬拉治疗增加了MVP患者的血小板存活率 (从2.4到2.7天).
结论:
- 缩短血小板存活时间与MVP和RHD患者的TE有关.
- 与MVP患者相比,没有TE的RHD患者表现出较高的血小板存活时间缩短的频率.
- 这些发现与在 mitra prolapse 中观察到的 TE 的较低发病率相关.
相关概念视频
Mitral Valve Prolapse I: Introduction
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Valve Prolapse III: Nursing Management
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...


